OYAGEN INC. Email Format
Biotechnology ResearchNew York, United States2-10 Employees
OYAGEN INC. is a biotechnology company focused on discovering, developing, and commercializing therapies that leverage RNA and DNA editing enzymes. Its work centers on transforming the editing process into therapeutic strategies, with an initial emphasis on combating HIV by targeting viral interactions with host editing enzymes. The company pursues proprietary assays and high-throughput screening to advance drug development and seeks to bring anti-HIV agents targeting Vif and APOBEC3G to market, while also offering expert testing and consulting services to academic and industry clients in related biochemistry, virology, and drug discovery fields.